TIGIT and colorectal carcinoma: In the same work, the authors validated their findings by analyzing disease-free survival (DFS) and OS according to TIGIT gene expression levels in bulk tumors from the TCGA CRC cohort, showing that patients with high TIGIT expression had better DFS and OS [42].